NEOGEN CORP (NEOG)
Health Care / Health Care Supplies
S&P SmallCap 600$9.40
Below average on several measures. Research carefully.
Consider Buy
Score based on 4 of 5 models — moderate confidence
Is NEOGEN CORP a Good Investment in 2026?
NEOGEN CORP (NEOG) scores 5.1 out of 10 on AlphaStocks' composite model, earning a Consider Buy rating. The Piotroski model is the most favorable, rating NEOGEN CORP as Neutral. However, the Greenblatt Magic Formula model rates it Caution — Bottom half (rank 97%). NEOGEN CORP currently trades below its estimated fair value of $10, suggesting potential upside. NEOGEN CORP ranks #544 out of 1127 stocks in the Health Care sector.
This summary is algorithmically generated and is not financial advice.
Key Metrics
Estimated Fair Value
Trading near or slightly below estimated fair value.
Model-based estimate, not a price target.
5-Model Analysis
Each model evaluates this stock from a different angle. Combined, they form the composite score above.
Piotroski
Neutral
3/9
Buffett
Caution
Business quality & competitive moat
Graham
Neutral
Price vs intrinsic value
Lynch
Neutral
Growth rate vs price (PEG)
Greenblatt
Caution
Bottom half (rank 97%)
Frequently Asked Questions
Is NEOGEN CORP (NEOG) a good investment?
What is NEOGEN CORP's Piotroski F-Score?
Is NEOG overvalued or undervalued?
How does NEOG compare to other Health Care stocks?
What do investment models say about NEOG?
Similar Stocks
Compare NEOG with
Scores are algorithm-generated research tools, not investment recommendations. Past performance does not guarantee future results. Always do your own due diligence. Full disclaimer